Trace Neuroscience aims to advance an RNA-binding therapy designed to preserve — and potentially improve — muscle function in ...

By scanning people's brains as they watched a handful of Hollywood flicks, scientists have created the most comprehensive map ...

The formation of Trace Neuroscience is based on simultaneous convergent discoveries from the company's co-founders linking abnormal function of TDP-43 protein with the loss of UNC13A protein, an ...

Trace Neuroscience Launches with $101 Million Series A Financing to Expand Genomic Medicine for Neurodegenerative Diseases, Including ALS ...

Trace Neu­ro­science, a start­up spun out of Maze Ther­a­peu­tics’ pipeline, broke cov­er Tues­day morn­ing with $101 ...

Almost all cases of ALS and half of frontotemporal dementia (FTD) cases are linked to dysfunction in a protein TDP-43.

For most of human history, that was the best a locked-in patient could hope for. Today, brain-machine interfaces offer much ...

While companies developing ALS therapies have struggled over the past year, Trace’s leaders told STAT they believe their ...

A recent study offers new insights into how brain regions coordinate during rest, using resting-state fMRI (rsfMRI) and neural recordings in mice.

In the early phase of Alzheimer’s disease, astrocytes are the primary source of APOE in the brain. This study examined the ...

This study describes a new analysis strategy to compare active neurons during behavioral tasks across the brain. This is significant because analysing how different brain areas are active during ...

A regression discontinuity analysis finds essentially no effect of 1 additional year of secondary education on brain structure in adulthood. This is a valuable finding that adds to the literature on ...